Related Experiment Videos
Protein kinase C in diabetic nephropathy
P A Craven1, R K Studer, H Negrete
1Veteran's Administration (VA) Medical Center, Pittsburgh, Pennsylvania, USA.
Journal of Diabetes and Its Complications
|October 1, 1995
Summary
Activation of protein kinase C by thromboxane in diabetic glomeruli stimulates transforming growth factor beta (TGF-β) production. This TGF-β then increases extracellular matrix synthesis, potentially causing mesangial expansion in diabetes.
Area of Science:
- Biochemistry
- Cell Biology
- Diabetic Nephropathy Research
Background:
- Protein kinase C (PKC) activation is observed in diabetic tissues and high glucose conditions.
- Elevated PKC activators like thromboxane are implicated in diabetic complications.
- Glomerular mesangial cells play a key role in kidney structure and are affected by diabetes.
Purpose of the Study:
- To investigate the role of thromboxane-induced protein kinase C activation in transforming growth factor beta (TGF-β) production by mesangial cells.
- To elucidate the mechanism by which PKC activation influences extracellular matrix (ECM) synthesis in diabetic conditions.
Main Methods:
- Utilized cultured mesangial cells exposed to various PKC activators, including thromboxane.
- Measured TGF-β bioactivity and mRNA expression.
- Assessed extracellular matrix protein synthesis.
Main Results:
- Thromboxane, a known elevated eicosanoid in diabetes, activates protein kinase C in mesangial cells.
- PKC activation by thromboxane leads to increased TGF-β production.
- TGF-β subsequently enhances extracellular matrix protein synthesis, independent of active PKC.
Conclusions:
- Activation of protein kinase C by thromboxane in diabetic glomeruli stimulates TGF-β production.
- Elevated TGF-β contributes to increased extracellular matrix synthesis.
- PKC activation in diabetes may drive mesangial expansion through enhanced TGF-β signaling.